6. Parkinson disease
2,123 clinical trials,   2,046 drugs   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-101198
01/4/2010A double-blind confirmatory study for AD-810N (zonisamide) in patients with Parkinson's disease (Phase III)A double-blind confirmatory study for AD-810N (zonisamide) in patients with Parkinson's disease (Phase III) Parkinson's diseaseIntervention name : Zonisamide
Dosage And administration of the intervention : Oral
Control intervention name : null
Dainippon Sumitomo Pharma Co., Ltd.NULL2074BOTH360Phase 3NULL
2JPRN-JapicCTI-070377
28/03/2007Double-blind, parallel-group confirmatory study of AD-810N (zonisamide) in patients with Parkinson's diseaseDouble-blind, parallel-group confirmatory study of AD-810N (zonisamide) in patients with Parkinson's disease Parkinson's diseaseIntervention name : AD-810N (zonisamide)
Dosage And administration of the intervention : oral
Dainippon Sumitomo Pharma Co., Ltd.NULL2074BOTHPhase 3NULL
3JPRN-JapicCTI-050099
12/09/2005Double blind, parallel-group clinical study of AD-810N (zonisamide) for Parkinson's diseaseDouble blind, parallel-group clinical study of AD-810N (zonisamide) for Parkinson's disease Parkinson's diseaseIntervention name : AD-810N (zonisamide)
Dosage And administration of the intervention : oral
Dainippon Sumitomo Pharma Co., Ltd.NULL2079BOTHNANULL